CN Patent

CN107625743B — 稳定化的包含核-壳微囊的局部制剂

Assigned to Shenzhen Beimei Pharmaceutical Co Ltd · Expires 2021-08-27 · 5y expired

What this patent protects

本发明涉及稳定化的包含核‑壳微囊的局部制剂。本公开内容涉及用于局部施用的组合物，其中所述组合物包含具有包含过氧化苯甲酰的核和包含无机聚合物的壳的微囊、具有包含类视黄醇的核和包含无机聚合物的壳的微囊、和稳定剂。所述组合物可为多种形式，例如乳液和凝胶。

USPTO Abstract

本发明涉及稳定化的包含核‑壳微囊的局部制剂。本公开内容涉及用于局部施用的组合物，其中所述组合物包含具有包含过氧化苯甲酰的核和包含无机聚合物的壳的微囊、具有包含类视黄醇的核和包含无机聚合物的壳的微囊、和稳定剂。所述组合物可为多种形式，例如乳液和凝胶。

Drugs covered by this patent

Patent Metadata

Patent number
CN107625743B
Jurisdiction
CN
Classification
—
Expires
2021-08-27
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Beimei Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.